Philip Green, MD
February 21st, 2014
Unpacking a Systematic Review of TAVR Research
Philip Green, MD and Kumar Dharmarajan, MD MBA
Philip Green and Kumar Dharmarajan explore how best to identify which patients benefit most from transcatheter aortic valve replacement.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?